🚀
Enjoy a 7-Day Free Trial Thru May 05, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Histogen Inc (OTCPK:HSTO)
News
Histogen Inc
OTCPK
:HSTO (USA) Â
$ 0.35
+0.0009 (+0.26%)
10:08 PM EST
P/E:
At Loss
P/B:
0.28
Market Cap:
$ 1.50M
Enterprise V:
$ -3.07M
Volume:
1.03K
Avg Vol (2M):
25.28K
Warning! GuruFocus detected 3 Severe warning signs with HSTO.
Try a 7-Day Free Trial
to check it out.
Also Trade In:
Volume:
1.03K
Market Cap $:
1.50M
PE Ratio:
At Loss
Avg Vol (2M):
25.28K
Enterprise Value $:
-3.07M
PB Ratio:
0.28
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Histogen Inc (OTCPK:HSTO) Stock News, Headlines & Updates
Histogen Inc Stock News from GuruFocus
Total 48
1
2
Apr 18, 2024
Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
GlobeNewswire
•
5:00pm
Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
Marketwired
•
5:00pm
Feb 13, 2024
Conatus Pharmaceuticals Inc and Histogen Inc Enter into Definitive Merger Agreement Conference Call Transcript
GuruFocus Research
•
4:15pm
Q4 2018 Conatus Pharmaceuticals Inc Earnings Call Transcript
GuruFocus Research
•
4:15pm
Sep 18, 2023
Histogen Announces Board Approval of Complete Liquidation and Dissolution
Marketwired
•
4:00pm
Jul 05, 2023
Histogen to Explore Strategic Alternatives
Marketwired
•
4:00pm
Jan 03, 2023
Histogen Hires Alfred P. Spada Ph.D. as Executive Vice President and Chief Scientific Officer
Stock market mentor
•
4:04pm
Jul 27, 2022
Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update
PurpleRose
•
4:00pm
Jul 14, 2022
Histogen Announces Closing of $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
PurpleRose
•
3:46pm
Jul 12, 2022
Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
PurpleRose
•
10:45am
Jun 16, 2022
Histogen to Present at the H.C. Wainwright Global Investment Conference
GuruFocusNews
•
4:10pm
Jun 06, 2022
Histogen to Present at the H.C. Wainwright Global Investment Conference
GuruFocusNews
•
4:09pm
May 17, 2022
Histogen to Present at the H.C. Wainwright Global Investment Conference
GuruFocusNews
•
3:07pm
Mar 25, 2022
Histogen Announces Closing of $4.75 Million Private Placement
GuruFocusNews
•
4:00pm
Dec 22, 2021
Histogen Announces Closing of $3.5 Million Private Placement
GuruFocusNews
•
6:00pm
Dec 16, 2021
Histogen Announces $3.5 Million Private Placement
GuruFocusNews
•
7:00am
Jun 30, 2021
Histogen Announces Initiation of HST 003 Phase 1/2 Trial for Knee Cartilage Regeneration
Marketwired
•
7:00am
Jun 03, 2021
Histogen Provides Update on its Development Programs and Pipeline Focus
Marketwired
•
8:01am
May 19, 2021
Histogen and Amerimmune Report Publication on Emricasan in COVID-19
Marketwired
•
7:01am
Mar 11, 2021
Histogen Strengthens Board of Directors with Appointment of Industry Leader Susan Windham-Bannister, Ph.D.
Marketwired
•
7:02pm
Mar 05, 2021
Histogen to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Business Update
Marketwired
•
7:01pm
Mar 02, 2021
Histogen to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
Marketwired
•
11:01am
Feb 16, 2021
Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
Marketwired
•
11:02am
Jan 20, 2021
Histogen Reports FDA Clinical Hold for Planned Phase 1/2 Trial of HST-003 for Knee Cartilage Regeneration
Marketwired
•
7:01pm
Jan 07, 2021
DLA Piper advises Histogen in its US$14 million upsized public offering
PRNewswire
•
11:02am
Jan 06, 2021
Histogen to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Marketwired
•
11:02am
Histogen Announces Closing of $14.0 Million Upsized Public Offering
Marketwired
•
6:59pm
Dec 31, 2020
Histogen Announces Pricing of $14.0 Million Upsized Public Offering
Marketwired
•
10:59pm
Histogen Announces Pricing of $14.0 Million Upsized Public Offering
GlobeNewswire
•
10:59pm
Dec 17, 2020
Histogen Announces Filing an Investigational New Drug Application for HST-003
Marketwired
•
7:01am
Dec 01, 2020
Histogen Announces Preliminary Week 18 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
Marketwired
•
7:01am
Nov 17, 2020
Histogen Announces Closing of $4.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Marketwired
•
7:01pm
Nov 12, 2020
Histogen Announces $4.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Marketwired
•
7:02am
Oct 29, 2020
Histogen to Report Third Quarter 2020 Earnings on November 12, 2020
Marketwired
•
7:01pm
Oct 27, 2020
Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19
Marketwired
•
11:01am
Oct 19, 2020
Histogen Appoints Moya Daniels as Executive Vice President and Head of Regulatory, Quality and Clinical Operations
Marketwired
•
11:01am
Oct 05, 2020
Histogen Announces Completion of Final Dosing Timepoint Milestone in its 1b/2a Trial for Androgenic Alopecia in Men
Marketwired
•
11:01am
Sep 29, 2020
Histogen Announces Update for its HST-002 Dermal Filler Program
Marketwired
•
11:00am
Sep 16, 2020
Histogen Announces $2M Grant Award from the Department of Defense for Clinical Advancement of HST-003 for Cartilage Regeneration in the Knee
Marketwired
•
11:00am
Sep 10, 2020
Histogen Announces Completion of Dosing Milestone in its 1b/2a Trial for Androgenic Alopecia in Men
Marketwired
•
11:01am
Total 48
1
2
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news